Bessemer Group’s Sana Biotechnology SANA Stock Holding History

Bessemer Group’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-89	Closed	–	–	2696
2025 Q2	$0	Hold	89	–	–	﹤0.01%	2613
2025 Q1	$0	Buy	+89	New	+$249	﹤0.01%	2698

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group's SANA Position: Q3 2025 in Review

Bessemer Group sold out of Sana Biotechnology (SANA) in Q3 2025, closing a stake of 89 shares.

Bessemer Group first reported a position in SANA in Q1 2025 and held it in 2 quarters. The position peaked at $0 in Q2 2025. 178 funds tracked by Wall St. Rank hold SANA as of Q3 2025.

Bessemer Group reported no remaining Sana Biotechnology position as of Q3 2025 after selling out during the quarter.
Bessemer Group sold 89 Sana Biotechnology shares in Q3 2025.
Bessemer Group first reported a position in Sana Biotechnology in Q1 2025 and held it in 2 quarters.
Bessemer Group's Sana Biotechnology position peaked at $0 in Q2 2025.
178 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2025.

Based on Bessemer Group's 13F filing for Q3 2025, filed 5 Nov 2025.